{
  "id": 10501137,
  "title": "Half of new US-approved drugs remain unavailable to Japanese patients",
  "url": "https://urgent.news/2026/09/28/half-of-new-us-approved-drugs-remain-unavailable-to-japanese-patients",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-28T16:16:53.000Z",
  "source": {
    "name": "Nikkei Asia",
    "slug": "nikkei-asia",
    "url": "https://asia.nikkei.com/business/pharmaceuticals/half-of-new-us-approved-drugs-remain-unavailable-to-japanese-patients"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}